摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

mono-6-deoxy-6-carboxy-β-cyclodextrin | 769884-11-9

中文名称
——
中文别名
——
英文名称
mono-6-deoxy-6-carboxy-β-cyclodextrin
英文别名
6-Deoxy-6-carboxy-β-cyclodextrin;(1S,3R,5R,6S,8S,10S,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,33R,35R,36R,37R,38R,39R,40R,41R,42R,43R,44R,45R,46R,47R,48R,49R)-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecahydroxy-5,15,20,25,30,35-hexakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-10-carboxylic acid
mono-6-deoxy-6-carboxy-β-cyclodextrin化学式
CAS
769884-11-9
化学式
C42H68O36
mdl
——
分子量
1148.98
InChiKey
NZJNPEQFQVIIBD-RSGLQJMASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    1577.1±65.0 °C(Predicted)
  • 密度:
    1.659±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -14.8
  • 重原子数:
    78
  • 可旋转键数:
    7
  • 环数:
    21.0
  • sp3杂化的碳原子比例:
    0.98
  • 拓扑面积:
    571
  • 氢给体数:
    21
  • 氢受体数:
    36

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    缩宫素mono-6-deoxy-6-carboxy-β-cyclodextrin1-羟基苯并三唑N,N'-二环己基碳二亚胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 49.0h, 以30%的产率得到
    参考文献:
    名称:
    Synthesis and pharmacological evaluation of a new targeted drug carrier system: β-Cyclodextrin coupled to oxytocin
    摘要:
    beta-Cyclodextrin (beta-CD) was monofunctionalized into its carboxylic derivative and then conjugated to the N-side of oxytocin (OT), a nonapeptide involved in human behavior and myometrium contraction. On isolated rat myometrium, this conjugate (beta-CD-OT) partly preserves the contracting activity of OT (EC50 = 0.40 mu M vs 1.7 nM). Moreover, the contraction induced frequency is also lowered by beta-CD-OT. This novel hydrophilic targeted carrier could form a host-guest complex with prostaglandins and their derivatives used as labor inducers or with anticancer drugs used in cervix and endometrial cancer. This strategy can improve the solubility, the stability, and/or the biological activity of these drugs as well as reducing their side-effects. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2008.02.017
  • 作为产物:
    描述:
    β-cyclodextrin monoaldehyde 在 phosphate buffer 、 作用下, 反应 120.0h, 以20%的产率得到mono-6-deoxy-6-carboxy-β-cyclodextrin
    参考文献:
    名称:
    Synthesis and pharmacological evaluation of a new targeted drug carrier system: β-Cyclodextrin coupled to oxytocin
    摘要:
    beta-Cyclodextrin (beta-CD) was monofunctionalized into its carboxylic derivative and then conjugated to the N-side of oxytocin (OT), a nonapeptide involved in human behavior and myometrium contraction. On isolated rat myometrium, this conjugate (beta-CD-OT) partly preserves the contracting activity of OT (EC50 = 0.40 mu M vs 1.7 nM). Moreover, the contraction induced frequency is also lowered by beta-CD-OT. This novel hydrophilic targeted carrier could form a host-guest complex with prostaglandins and their derivatives used as labor inducers or with anticancer drugs used in cervix and endometrial cancer. This strategy can improve the solubility, the stability, and/or the biological activity of these drugs as well as reducing their side-effects. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2008.02.017
点击查看最新优质反应信息

文献信息

  • Selective oxidation of primary alcohol groups of β-cyclodextrin mediated by 2,2,6,6-tetramethylpiperidine-1-oxyl radical (TEMPO)
    作者:Carole Fraschini、Michel R. Vignon
    DOI:10.1016/s0008-6215(00)00129-4
    日期:2000.10
    Beta-cyclodextrin (beta-CD) was reacted with catalytic amounts of 2,2,6,6-tetramethylpiperidine-1-oxyl radical (TEMPO), sodium hypochlorite and sodium bromide at 2 degrees C and a pH value of 10 in water. The primary alcohol groups were selectively oxidized into carboxylate groups within a few minutes, and mono- and dicarboxy-beta-cyclodextrin sodium salts were isolated and characterized by 1H, 13C
    在2摄氏度和pH值为10的水中,将β-环糊精(β-CD)与催化量的2,2,6,6-四甲基哌啶-1-氧基(TEMPO),次氯酸钠和溴化钠反应。在几分钟内将伯醇基团选择性地氧化成羧酸根基团,并分离出单羧基和二羧基-β-环糊精钠盐,并通过1H,13C NMR和质谱进行了表征。通过该反应系统,环氧化糊精的降解受到限制,条件是该氧化反应需在2摄氏度,恒定pH值为10的条件下进行,并使用催化量的TEMPO和受控量的次氯酸钠和溴化钠进行连续再生。氧铵盐。
  • A General Method for the Synthesis of Cyclodextrinyl Aldehydes and Carboxylic Acids
    作者:Juyoung Yoon、Sungyeap Hong、Kristy A. Martin、Anthony W. Czarnik
    DOI:10.1021/jo00114a030
    日期:1995.5
    The selective synthesis of the primary-side monoaldehyde of beta-cyclodextrin, 6-deoxy-6-formyl-beta-cyclodextrin, was accomplished by oxidation of the corresponding tosylate utilizing the Nace reaction (DMSO/collidine). This monoaldehyde was then used as the starting material in several reactions including reduction, addition of NaHSO3, addition of the alpha-nucleophiles hydroxylamine and hydrazine, and reductive amination. Of particular interest is the conversion of the monoaldehyde to the primary side carboxylic acid, 6-deoxy-6-carboxy-beta-cyclodextrin, via bromine oxidation. This general method sequence can be applied to any tosyl derivative of cyclodextrin as demonstrated in the synthesis of beta-cyclodextrin-A,D-dialdehyde and beta-cyclodextrin-A,D-diacid.
  • Synthesis and pharmacological evaluation of a new targeted drug carrier system: β-Cyclodextrin coupled to oxytocin
    作者:Carine Bertolla、Stéphanie Rolin、Brigitte Evrard、Lionel Pochet、Bernard Masereel
    DOI:10.1016/j.bmcl.2008.02.017
    日期:2008.3
    beta-Cyclodextrin (beta-CD) was monofunctionalized into its carboxylic derivative and then conjugated to the N-side of oxytocin (OT), a nonapeptide involved in human behavior and myometrium contraction. On isolated rat myometrium, this conjugate (beta-CD-OT) partly preserves the contracting activity of OT (EC50 = 0.40 mu M vs 1.7 nM). Moreover, the contraction induced frequency is also lowered by beta-CD-OT. This novel hydrophilic targeted carrier could form a host-guest complex with prostaglandins and their derivatives used as labor inducers or with anticancer drugs used in cervix and endometrial cancer. This strategy can improve the solubility, the stability, and/or the biological activity of these drugs as well as reducing their side-effects. (C) 2008 Elsevier Ltd. All rights reserved.
查看更多